BeOne Medicines Ltd. (ONC) has 9 known insider and institutional holders on record. The largest holder is OYLER JOHN with 5,491,339 shares. Other notable holders include Wang Xiaodong and Wang Lai.
Over the last 12 months, insiders have made 47 transactions in ONC stock — 14 buys (valued at $20.15M) and 29 sells (valued at $5.51M). Insider selling has exceeded buying during this period.
ONC Insider Ownership
Top Holder
OYLER JOHN
5,491,339 shares
Buys (12 mo)
14
$20.15M value
Sells (12 mo)
29
$5.51M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Oyler John |
Chief Executive Officer |
5,491,339 |
2026-03-10 |
|
| 2 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
4,582,601 |
2025-11-12 |
|
| 3 |
Wang Lai |
President, Global Head of R&d |
1,564,030 |
2026-03-10 |
|
| 4 |
Wu Xiaobin |
President and COO |
1,137,900 |
2026-03-10 |
|
| 5 |
Rosenberg Aaron |
Chief Financial Officer |
294,346 |
2026-03-10 |
|
| 6 |
Lee Chan Henry |
SVP, General Counsel |
288,496 |
2026-03-10 |
|
| 7 |
Ball Titus B. |
Principal Accounting Officer |
73,983 |
2025-06-12 |
|
| 8 |
Baker Bros. Advisors Lp |
Director |
45,500 |
2025-05-22 |
|
| 9 |
Yi Qingqing |
Director |
27,326 |
2025-06-12 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-11 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
341 |
$300.00 |
$102.3K |
| 2026-03-06 |
Rosenberg Aaron |
Chief Financial Officer |
RSU Award |
79,014 |
- |
- |
| 2026-03-06 |
Lee Chan Henry |
SVP, General Counsel |
RSU Award |
65,390 |
- |
- |
| 2026-03-06 |
Wang Lai |
President, Global Head of R&d |
RSU Award |
112,606 |
- |
- |
| 2026-03-06 |
Wu Xiaobin |
President and COO |
RSU Award |
168,922 |
- |
- |
| 2026-03-06 |
Oyler John |
Chief Executive Officer |
RSU Award |
326,976 |
- |
- |
| 2026-02-04 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
996 |
$350.00 |
$348.6K |
| 2026-01-07 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
664 |
$331.76 |
$220.29K |
| 2025-12-31 |
Wang Lai |
President, Global Head of R&d |
RSU Award |
427,895 |
- |
- |
| 2025-12-16 |
Oyler John |
Chief Executive Officer |
Informative Sell |
40 |
$305.24 |
$12.21K |
| 2025-12-15 |
Oyler John |
Chief Executive Officer |
Informative Sell |
1,194 |
$314.92 |
$376.01K |
| 2025-12-11 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
332 |
$325.00 |
$107.9K |
| 2025-12-10 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
332 |
$318.28 |
$105.67K |
| 2025-11-26 |
Sanders Corazon (corsee) D. |
Director |
Informative Sell |
804 |
$342.47 |
$275.35K |
| 2025-11-17 |
Wu Xiaobin |
President and COO |
Informative Sell |
10 |
$382.32 |
$3.82K |
| 2025-11-12 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
332 |
$350.00 |
$116.2K |
| 2025-11-13 |
Wu Xiaobin |
President and COO |
Informative Sell |
1,769 |
$381.05 |
$674.08K |
| 2025-11-12 |
Wu Xiaobin |
President and COO |
Informative Sell |
154 |
$362.07 |
$55.76K |
| 2025-11-12 |
Oyler John |
Chief Executive Officer |
Gift (Given) |
858,533 |
- |
- |
| 2025-11-11 |
Oyler John |
Chief Executive Officer |
Gift (Given) |
151,320 |
- |
- |
| 2025-11-07 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Gift (Given) |
424,073 |
- |
- |
| 2025-10-08 |
Lee Chan Henry |
SVP, General Counsel |
Option Exercise |
296 |
$159.03 |
$47.07K |
| 2025-06-23 |
Wang Lai |
Global Head of R&d |
Informative Sell |
1,028 |
$260.00 |
$267.28K |
| 2025-06-23 |
Wu Xiaobin |
President and COO |
Informative Sell |
1,363 |
$260.00 |
$354.38K |
| 2025-06-24 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
100 |
$267.81 |
$26.78K |
